Table 2.
Génotypes and anti viral therapies
| Genotype | Treatment option | Comment |
|---|---|---|
| Genotype 1a | Ombitasvir–paritaprevir–ritonavir and dasabuvir + reduced-dose ribavirin (200 mg thrice weekly to 200 mg once daily) | Triple therapy- PegIFN + sofosbuvir/simeprevir/faldaprevir IFN free sofosbuvir + RBV |
| Genotype1b | Ombitasvir–ritonavir + dasabuvir | Limited data |
| Genotype 2 | IFN free sofosbuvir + RBV | |
| Genotype 3 | Triple therapy IFN free sofosbuvir + RBV |
|
| Genotype 4 | PegIFN + sofosbuvir + RBV | |
| Genotype 5/6 | PegIFN + sofosbuvir + RBV |
RBV ribavirin, IFN interferon